Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 4;8(9):e73166.
doi: 10.1371/journal.pone.0073166. eCollection 2013.

Prevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adults

Katja Marja Hakkarainen  1 , Karolina Andersson Sundell, Max Petzold, Staffan Hägg
Affiliations

Prevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adults

Katja Marja Hakkarainen et al. PLoS One. .

Abstract

Purpose: Adverse drug events (ADEs) are common and often preventable among inpatients, but self-reported ADEs have not been investigated in a representative sample of the general public. The objectives of this study were to estimate the 1-month prevalence of self-reported ADEs among the adult general public, and the perceived preventability of 2 ADE categories: adverse drug reactions (ADRs) and sub-therapeutic effects (STEs).

Methods: In this cross-sectional study, a postal survey was sent in October 2010 to a random sample of 13 931 Swedish residents aged ≥ 18 years. Self-reported ADEs experienced during the past month included ADRs, STEs, drug dependence, drug intoxications and morbidity due to drug-related untreated indication. ADEs could be associated with prescription, non-prescription or herbal drugs. The respondents estimated whether ADRs and STEs could have been prevented. ADE prevalences in age groups (18-44, 45-64, or ≥65 years) were compared.

Results: Of 7099 respondents (response rate 51.0%), ADEs were reported by 19.4% (95% confidence interval, 18.5-20.3%), and the prevalence did not differ by age group (p>0.05). The prevalences of self-reported ADRs, STEs, and morbidities due to drug-related untreated indications were 7.8% (7.2-8.4%), 7.6% (7.0-8.2%) and 8.1% (7.5-8.7%), respectively. The prevalence of self-reported drug dependence was 2.2% (1.9-2.6%), and drug intoxications 0.2% (0.1-0.3%). The respondents considered 19.2% (14.8-23.6%) of ADRs and STEs preventable. Although reported drugs varied between ADE categories, most ADEs were attributable to commonly dispensed drugs. Drugs reported for all and preventable events were similar.

Conclusions: One-fifth of the adult general public across age groups reported ADEs during the past month, indicating a need for prevention strategies beyond hospitalised patients. For this, the underlying causes of ADEs should increasingly be investigated. The high burden of ADEs and preventable ADEs from widely used drugs across care settings supports redesigning a safer healthcare system to adequately tackle the problem.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Study flow diagram.
See this image and copyright information in PMC

References

    1. World Health Organization (2009) WHO patient safety research - Better knowledge for safer care. France: World Health Organization.
    1. Ministry of Health and Social Affairs (2011) National medication strategy [in Swedish]. Stockholm: Ministry of Health and Social Affairs.
    1. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, et al. (1995) Incidence of adverse drug events and potential adverse drug events: Implications for prevention. ADE prevention study group. JAMA 274: 29–34. - PubMed
    1. Leendertse AJ, Visser D, Egberts AC, van den Bemt PM (2010) The relationship between study characteristics and the prevalence of medication-related hospitalizations: A literature review and novel analysis. Drug Saf 33: 233–244 10.2165/11319030-000000000-00000. - PubMed
    1. Aronson JK, Ferner RE (2005) Clarification of terminology in drug safety. Drug Saf 28: 851–870. - PubMed

Publication types